NCT04857905 2024-01-05
Dose-staged Gamma Knife Radiosurgery Versus Microsurgical Resection
Medical University of Vienna
Phase NA Unknown
Clinical Trials
17 trialsNCT03458455 2023-11-01
TREATMENT
Oslo University Hospital
Unknown
NCT05144867 2023-10-17
SRSvsWBRT
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 3 Unknown
NCT02953717 2023-09-13
Cognitive Outcome After SRS or WBRT in Patients With Multiple Brain Metastases (CAR-Study B)
Elisabeth-TweeSteden Ziekenhuis
Phase NA Unknown
NCT04671459 2023-06-28
TaRRGET
Prof. Franciszek Lukaszczyk Memorial Oncology Center
Phase 2 Unknown
NCT05611645 2022-11-10
Low-dose Bevacizumab With HSRT vs BVZ Alone for GBM at First Recurrence
Huashan Hospital
Phase 2 Unknown
NCT03286023 2022-06-22
CKBrainMeta
Centre Francois Baclesse, Luxembourg
Unknown
NCT05177185 2022-02-16
HiSparCK
Ottawa Hospital Research Institute
Phase 2 Unknown
NCT05131711 2021-11-23
CSREIG
Beijing Tiantan Hospital
Phase 1/2 Unknown
NCT02055859 2021-02-21
ACOUNEU
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Phase NA Unknown
NCT02974127 2021-02-21
MuRaLM
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Unknown
NCT01535209 2012-02-17
Stereotactic Radiotherapy of Resection Cavity For Single Brain Metastasis Versus Whole-Brain Radiotherapy After Resection
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 3 Unknown
NCT01449604 2011-10-10
Stereotactic Radiation in Vestibular Schwannoma
Ramathibodi Hospital
Phase 3 Unknown
NCT01353573 2011-05-13
TRICK
Hamilton Health Sciences Corporation
Phase 3 Unknown
NCT00484978 2007-06-12
Stereotactic Radiosurgery to the Resection Cavity Following Surgical Removal of Brain Metastasis
Tel-Aviv Sourasky Medical Center
Phase 2 Unknown
NCT00457210 2007-04-06
The Influence of Radiotherapy on Cognitive Function
Tel-Aviv Sourasky Medical Center
Unknown
NCT00004659 2005-06-24
Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors
Office of Rare Diseases (ORD)
Phase 2 Unknown